1Harvey PD, Pappadopulos E, Lombardo I, et al. Reduction of func- tional disability with atypical antipsychotic treatment ; a random- ized long term comparison of ziprasidone and haloperidol [J]. Schizophr Res ,2009,115 ( 1 ) ;24 - 29.
2Villari V, Rocca P, Fonzo Vet al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation [ J]. Prog Neu- ropsychopharmacol Biol Psychiatry,2008,32 ( 2 ) :405 - 413.
3J Yang,T Chen,L Sun,et al.Potential metabolite markers of schizophrenia[J].Molecular Psychiatry,2013,18:67-78.
4Joris A,Veltman&Han G,Brunne.De novomutations in human genetic disease[J].Nature,2012,13:565-575.